Gutiérrez MJ

Idioma: Español
Referencias bibliográficas: 35
Paginas: 159-160
Archivo PDF: 127.89 Kb.

FRAGMENTO

La meningitis bacteriana en el primer mes de vida es la infección más común del sistema nervioso central, incluso más que en cualquier otro momento de la vida. Su incidencia varía de 0.5 a 3.2 por 1,000 nacidos vivos. Debido al avance de las nuevas tecnologías y terapias, los pacientes tienen una mayor supervivencia, lo cual se aprecia en la tasa de mortalidad que ha disminuido desde 50% en la década de los años 70 a 10-15% en la actualidad, pero no así las secuelas neurológicas y discapacidades que esta infección ocasiona a largo plazo,3-9 las cuales no se han modificado.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Wenger JD, Hightower AW, Facklam RR, et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990; 162:1316.

2. Holt DE, Halket S, Louvois J, Harvey D. Neonatal meningitis in England and Wales: 10 years on. Arch Dis Child Fetal Neonatal Ed 2001; 84: 85-9.

3. Klein JO. Bacterial sepsis and meningitis. In: Remmington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia: W.B. Saunders Company, 2001;979-80.

4. Harvey D, Holt DE, Bedford H. Bacterial meningitis in the newborn: a prospective study of mortality and morbidity. Semin Perinatol 1999; 23:218.

5. de Louvois J, Halket S, Harvey D. Neonatal meningitis in England and Wales: sequelae at 5 years of age. Eur J Pediatr 2005; 164:730.

6. Bortolussi R, Krishnan C, Armstrong D, Tovichayathamrong P. Prognosis for survival in neonatal meningitis: clinical and pathologic review of 52 cases. Can Med Assoc J 1978; 118:165.

7. Chang CJ, Chang WN, Huang LT, et al. Neonatal bacterial meningitis in southern Taiwan. Pediatr Neurol 2003; 29:288.

8. Smith PB, Cotten CM, Garges HP, et al. A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis. J Perinatol 2006; 26:111.

9. Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004; 363:292–294

10. Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998; 17:593.

11. Barton L, Hodgman JE, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999; 103:446.

12. Groover RV, Sutherland JM, Landing BH. Purulent meningitis of newborn infants. Eleven-year experience in the antibiotic era. N Engl J Med 1961; 264:1115.

13. Overall JC Jr. Neonatal bacterial meningitis. Analysis of predisposing factors and outcome compared with matched control subjects. J Pediatr 1970; 76:499.

14. Kelly S. Septicemia in galactosemia. JAMA 1971; 216:330.

15. Levy HL, Sepe SJ, Shih VE, et al. Sepsis due to Escherichia coli in neonates with galactosemia. N Engl J Med 1977; 297:823.

16. Unhanand M, Mustafa MM, McCracken GH Jr, Nelson JD. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J Pediatr 1993; 122:15.

17. Pong A, Bradley JS. Bacterial meningitis and the newborn infant. Infect Dis Clin North Am 1999; 13:711

18. Nizet, V, Klein, JO. Bacterial sepsis and meningitis. In: Infectious Diseases of the Fetus and Newborn Infant, 7th ed, Remington, JS, Klein, JO, Wilson, CB, et al (Eds), Elsevier Saunders, Philadelphia 2011. p.222

19. Overall JC Jr. Neonatal bacterial meningitis. Analysis of predisposing factors and outcome compared with matched control subjects. J Pediatr 1970; 76:499.

20. May M, Daley AJ, Donath S, et al. Early onset neonatal meningitis in Australia and New Zealand, 1992-2002. Arch Dis Child Fetal Neonatal Ed 2005; 90:F324.

21. Bortolussi R, Krishnan C, Armstrong D, Tovichayathamrong P. Prognosis for survival in neonatal meningitis: clinical and pathologic review of 52 cases. Can Med Assoc J 1978; 118:165.

22. Klinger G, Chin CN, Beyene J, Perlman M. Predicting the outcome of neonatal bacterial meningitis. Pediatrics 2000; 106:477.

23. Edwards MS, Rench MA, Haffar AA, et al. Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr 1985; 106:717.

24. Franco SM, Cornelius VE, Andrews BF. Long-term outcome of neonatal meningitis. Am J Dis Child 1992; 146:567.

25. Unhanand M, Mustafa MM, McCracken GH Jr, Nelson JD. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J Pediatr 1993; 122:15.

26. Anderson SG, Gilbert GL. Neonatal gram negative meningitis: a 10-year review, with reference to outcome and relapse of infection. J Paediatr Child Health 1990; 26:212.

27. Greenberg RG, Benjamin DK Jr, Cohen-Wolkowiez M, et al. Repeat lumbar punctures in infants with meningitis in the neonatal intensive care unit. J Perinatol 2011; 31:425.

28. Jordan HT, Farley MM, Craig A, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate,population-based analysis. Pediatr Infect Dis J 2008; 27:1057–1064.

29. Centers for Disease Control and Prevention. Early-onset and late-onset neonatal group B streptococcal disease: United States, 1996–2004. Morb Mortal Wkly Rep 2005; 54:1205–1208

30. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342:15–20

31. Curtis C, Shetty N. Recent trends and prevention of infection in the neonatal intensive care unit. Curr Opin Infect Dis 2008; 21:350–356.

32. Yang HH, Madoff LC, Guttormsen HK, et al. Recombinant group B streptococcus beta C protein and a variant with the deletion of its immunoglobulin A binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines. Infect Immun 2007; 75:3455–3461.

33. Yung HH, Mascuch SJ, Madoff LC, Paoletti LC. Recombinant group B streptococcus alpha-like protein 3 is an effective immunogen and carrier protein. Clin Vaccine Immunol 2008; 15:1035–1041.

34. Heath PT, Feldman RG. Vaccination against group B streptococcus. Expert Rev Vaccines 2005; 4:207–218.

35. Margarit I, Rinaudo CD, Galeotti CL, et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis 2009;199:108–115.